Drug Shortage Report for TOBI
| Report ID | 192953 |
| Drug Identification Number | 02239630 |
| Brand name | TOBI |
| Common or Proper name | TOBRAMYCIN |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | TOBRAMYCIN |
| Strength(s) | 300MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INHALATION INHALATION |
| Packaging size | 56 AMPULES |
| ATC code | J01GB |
| ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2023-06-01 |
| Actual start date | 2023-05-31 |
| Estimated end date | 2024-10-01 |
| Actual end date | 2024-05-31 |
| Shortage status | Resolved |
| Updated date | 2024-10-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v17 | 2023-10-17 | French | Compare |
| v16 | 2023-10-17 | English | Compare |
| v15 | 2023-10-11 | French | Compare |
| v14 | 2023-10-11 | English | Compare |
| v13 | 2023-09-20 | French | Compare |
| v12 | 2023-09-20 | English | Compare |
| v11 | 2023-09-11 | French | Compare |
| v10 | 2023-09-11 | English | Compare |
| v9 | 2023-07-18 | French | Compare |
| v8 | 2023-07-18 | English | Compare |
| v7 | 2023-06-13 | French | Compare |
| v6 | 2023-06-13 | English | Compare |
| v5 | 2023-06-02 | English | Compare |
| v4 | 2023-05-31 | French | Compare |
| v3 | 2023-05-31 | English | Compare |
| v2 | 2023-05-24 | French | Compare |
| v1 | 2023-05-24 | English | Compare |